Middlemen get rebates on medicines. They should share those savings with you.
There’s a long line of middlemen profiting when you get your medicine. In fact, pharmacy benefit managers (PBMs) negotiate rebates that can lower costs of some medicines by 50% or more. Yet, they can charge you full price at the pharmacy. Congress should make sure medicine savings go directly to patients, not middlemen.
Over half of every dollar spent on medicines goes to middlemen and others.
Patients are paying more than they should and facing barriers to care because middlemen are using medicines as a profit center. In fact, over half of every dollar spent on medicines goes to health insurance companies, PBMs, big pharmacies, and others. They are driving up costs for patients.
Over half of every dollar spent on medicines goes to middlemen and others.
Patients are paying more than they should and facing barriers to care because middlemen are using medicines as a profit center. In fact, over half of every dollar spent on medicines goes to health insurance companies, PBMs, big pharmacies, and others. They are driving up costs for patients.
Middlemen wield enormous power over patients.
Insurers and PBMs decide what medicines you can get and the price you pay at the pharmacy. Just three PBMs control 80% of the prescription drug market and the largest PBMs and insurers are owned by the same big health care conglomerates. They are consolidating their power even further by owning pharmacies and buying up doctors’ offices.
Middlemen refuse to share savings with patients.
Insurers and PBMs get billions of dollars in rebates and discounts that reduce the cost of brand medicines by 50% or more. Yet, they often force patients to pay based on the full price. As a result, patients can pay more for medicines than middlemen.
When patients use copay assistance to save money at the pharmacy, middlemen keep it for themselves or refuse to count it toward patients’ deductibles.
Middlemen drive up costs for everyone.
PBMs make money off fees and rebates tied to the price of medicines, which means they make more money when the price of medicines go up. Experts say this can lead them to deny or limit coverage of lower-cost medicines driving up costs for everyone while their profits soar.
Middlemen can profit from where you fill your prescription.
PBMs often steer people toward the pharmacies they own, regardless of what is in the best interest of the patient. A new FTC report shows this creates conflicts of interests that can increase medicine costs and squeeze out independent pharmacies.
Make sure savings go directly to patients, not middlemen.
PBMs receive billions in savings on medicines but often fail to pass these on to patients. Middlemen are putting profits before patents and driving up out-of-pocket costs.
It’s time to lower costs for patients by taking on the middlemen.
Related Resources
FTC report confirms PBMs profit at the expense of patients
Pharmacy Benefit Managers (PBMs) are “powerful middlemen inflating drug costs and squeezing Main Street pharmacies,” according to a new report from the Federal Trade Commission (FTC).
New 50-state poll: Americans want to hold health insurers and PBMs accountable for high out-of-pocket costs and other harmful practices
Heading into the November elections, Americans want policymakers to address their real pain points and work towards solutions that hold big insurers and their PBM accountable.
ICYMI: Hidden markups at mail-order pharmacies increase costs for employers
A new in-depth report by the Wall Street Journal shows that mail-order pharmacies, often owned by big pharmacy benefit managers (PBMs), are driving up costs for employers when they were supposed to do the opposite.
ICYMI: "The Opaque Industry Secretly Inflating Prices for Prescription Drugs"
Pharmacy benefit managers (PBMs) are driving up drug costs for millions of people, employers and the government. That’s what the New York Times found after reviewing court documents and patient records and interviewing more than 300 individuals – experts, insiders, patients, physicians and others.
New analysis shows PBMs use fees as a profit center
Pharmacy benefit managers (PBMs) demand more than double the amount of fees today than they did five years ago, according to a new report from Nephron Research.
Hold PBMs Accountable: Rein in Middlemen Tactics that Harm Patients
By demanding more accountability and transparency, Congress can help rein in abusive PBM practices and provide meaningful relief to patients and taxpayers.
Share the Savings: If Insurers Don’t Pay Full Price for Medicines, Seniors Shouldn’t Either
Many Medicare beneficiaries struggle to afford the medicines they need, even as insurers and pharmacy benefit managers (PBMs) in the Part D program receive significant rebates from drug manufacturers that lower the prices they pay for medicines.
Protect Copay Assistance: End Insurer and Middlemen Games That Drive Up Costs for Patients
Patients continue to show up at the pharmacy counter and realize their commercial health insurance coverage doesn’t provide the level of access and affordability they need. A big reason is because insurers and pharmacy benefit managers are shifting more costs onto patients through higher use of deductibles and coinsurance.
A Voter's Perspective: Alfred and Rebecca
Pharmacist, Dad, and Patient
Voters like Alfred and Rebecca, who live in Kentucky, overwhelmingly support solutions to help rein in insurance companies and their pharmacy benefit managers (PBMs). Join them in raising your voice to ensure that patients and doctors are the ones making decisions about medications, not PBMs who are more focused on bottom lines than quality of life.